CNR1 and glioblastoma: Cannabinoid-mediated activation of the CB1 and CB2 receptors inhibits the PI3K/Akt/mTOR pathway in glioblastoma cells, which reduces cell growth and promotes apoptosis and autophagy (Salazar et al., 2009).